BeStock  
Stocks › Biotechnology › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2154Biotechnology
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–

Earnings

Average move on report day±2.9%last 7 reports
Closed higher2 of 729% of the time
Best reaction+2.0%
Worst reaction-4.3%

Stock move on the day after each report

-4.3%2024/Q1+2.0%2024/Q2-3.2%2024/Q3+1.2%2025/Q1-4.2%2025/Q2-1.6%2025/Q3-3.8%2026/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q17 May 2026Pre Market±10.8%-3.81%Within range
2025/Q36 Nov 2025Pre Market±31.0%-1.61%Within range
2025/Q27 Aug 2025Pre Market±12.0%-4.18%Within range
2025/Q18 May 2025Pre Market±12.7%+1.24%Within range
2024/Q37 Nov 2024Pre Market±13.0%-3.25%Within range
2024/Q28 Aug 2024Pre Market±32.2%+1.95%Within range
2024/Q19 May 2024Pre Market–-4.26%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$46.14M+1.5% YoY
Net profit$1.17B+2,967.6% YoY
Diluted EPS$9.65+2,574.4% YoY
Free cash flow-$78.31M-124.6% YoY
Operating cash flow-$78.29M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-39.7MDec '24$-40.8MMar '25$-36.1MJun '25$-40.7MSep '25$-50.2MDec '25$-49.0MMar '26$-57.3MJun '26$1.2BSep '26

Profitability & balance sheet

Return on equity92.1%
Return on assets85.4%
Return on invested capital90.1%
Current ratio12.30
Liabilities / assets8.3%
Cash & investments$1.74B
Total debt$2.36M
Net cash (debt)$1.74B

Discussion

No comments yet — be the first to weigh in on EWTX.

Sign in to join the discussion.

Scroll to Top